Intestinal Hormones and Regulation of Satiety: The Case for CCK,GLP-1,PYY,and Apo A-IV

Abstract

Satiety, the physiologic processes that combine to bring about the cessation of a meal, is controlled in part by intestinal peptide secretion. The effects of cholecystokinin, glucagon-like peptide I, peptide YY, and apolipoprotein A-IV are described.

Get full access to this article

View all access options for this article.

References

Woods SC. Dietary synergies in appetite control: distal gastrointestinal tract. Obesity (Silver Spring). 2006 ;14(suppl 4):171S -178S.

Greenberg D. Intestinal satiety. In: Smith GP, ed. Satiation From Gut to Brain. New York, NY: Oxford University Press;1998 : 40-70.

Liddle RA. Cholecystokinin. In: Dockray GJ, Walsh JH, eds.Gut Peptides. New York, NY: Raven Press; 1994:175 -216.

Reidelberger RD, Hernandez J, Fritzsch B, Hulce M. Abdominal vagal mediation of the satiety effects of CCK in rats. Am J Physiol Regul Integr Comp Physiol. 2004;286:R1005 -R1012.

Gibbs J, Young RC, Smith GP. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature. 1973 ;245:323 -325.

Schwartz GJ, Moran TH. Duodenal nutrient exposure elicits nutrient-specific gut motility and vagal afferent signals in rat. Am J Physiol. 1998;274:R1236 -R1242.

Barrachina MD, Martinez V, Wang L, Wei JY, Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci U S A. 1997 ;94:10455 -10460.

Morton GJ, Blevins JE, Williams DL, et al. Leptin action in the forebrain regulates the hindbrain response to satiety signals. J Clin Invest. 2005;115:703 -710.

D'Alessio DA, Vahl TP. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes. Am J Physiol Endocrinol Metab. 2004;286:E882 -E890.

10.

Kinzig KP, D'Alessio DA, Seeley RJ. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci. 2002 ;22:10470 -10476.

11.

Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3:153 -165.

12.

Williams DL, Baskin DG, Schwartz MW. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation.Diabetes. 2006;55:3387 -3393.

13.

Seeley RJ, Blake K, Rushing PA, et al. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci. 2000 ;20:1616 -1621.

14.

Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002 ;418:650 -654.

15.

Halatchev IG, Cone RD. Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice. Cell Metab. 2005 ;1:159 -168.

16.

Moran TH, Smedh U, Kinzig KP, Scott KA, Knipp S, Ladenheim EE. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol. 2005;288:R384 -R388.

17.

Degen L, Oesch S, Casanova M, et al. Effect of peptide YY3-36 on food intake in humans. Gastroenterology. 2005 ;129:1430 -1436.

18.

Tso P, Liu M, Kalogeris TJ. The role of apolipoprotein A-IV in food intake regulation. J Nutr. 1999 ;129:1503 -1506.

19.

Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.J Clin Invest. 1993;91:1830 -1833.